Mr. Speaker, in May, the government signed with Chinese pharmaceutical giant CanSino to manufacture a COVID-19 vaccine. In late August, the deal fell apart. It was not until September 16 that the government opened up a new approval stream for COVID-19 vaccines that could be imported to Canada. The first approvals were not applied for until October.
Why did the Prime Minister cost Canadians five months in the vaccine race because he wanted to partner with China?